[HTML][HTML] The potential role of drug transporters and amikacin modifying enzymes in M. avium
JA Schildkraut, JPM Coolen, C Ruesen… - Journal of Global …, 2023 - Elsevier
Objectives Mycobacterium avium (M. avium) complex bacteria cause opportunistic infections
in humans. Treatment yields cure rates of 60% and consists of a macrolide, a rifamycin, and …
in humans. Treatment yields cure rates of 60% and consists of a macrolide, a rifamycin, and …
[PDF][PDF] The potential role of drug transporters and amikacin modifying enzymes in M. avium
JA Schildkraut, JPM Coolen, C Ruesen… - 2023 - repository.ubn.ru.nl
abstract Objectives: Mycobacterium avium (M. avium) complex bacteria cause opportunistic
infections in humans. Treatment yields cure rates of 60% and consists of a macrolide, a …
infections in humans. Treatment yields cure rates of 60% and consists of a macrolide, a …
[引用][C] The potential role of drug transporters and amikacin modifying enzymes in M. avium.
JA Schildkraut, JPM Coolen, C Ruesen… - 2023 - rivm.openrepository.com
The potential role of drug transporters and amikacin modifying enzymes in M. avium. Toggle
navigation Login Toggle navigation View Item Home Articles and other publications by RIVM …
navigation Login Toggle navigation View Item Home Articles and other publications by RIVM …
The potential role of drug transporters and amikacin modifying enzymes in M. avium.
JA Schildkraut, JPM Coolen, C Ruesen… - Journal of Global …, 2023 - europepmc.org
Background Mycobacterium avium complex bacteria cause opportunistic infections in
humans. Treatment yields cure rates of 60% and is comprised of a macrolide, a rifamycin …
humans. Treatment yields cure rates of 60% and is comprised of a macrolide, a rifamycin …
The potential role of drug transporters and amikacin modifying enzymes in M. avium.
JA Schildkraut, JPM Coolen, C Ruesen… - 2023 - cabidigitallibrary.org
Objectives: Mycobacterium avium (M. avium) complex bacteria cause opportunistic
infections in humans. Treatment yields cure rates of 60% and consists of a macrolide, a …
infections in humans. Treatment yields cure rates of 60% and consists of a macrolide, a …
The potential role of drug transporters and amikacin modifying enzymes in M. avium
JA Schildkraut, JPM Coolen, C Ruesen… - Journal of global … - pubmed.ncbi.nlm.nih.gov
Objectives Mycobacterium avium (M. avium) complex bacteria cause opportunistic infections
in humans. Treatment yields cure rates of 60% and consists of a macrolide, a rifamycin, and …
in humans. Treatment yields cure rates of 60% and consists of a macrolide, a rifamycin, and …